V. Piotrovsky

Population Cell Life Span Models for Effects of Drugs Following Indirect Mechanisms of Action

W. Jusko, J. Pérez-Ruixo, A. Chow, 2005, Journal of Pharmacokinetics and Pharmacodynamics.

Effects of demographic variables on vorozole pharmacokinetics in healthy volunteers and in breast cancer patients

A. Peer, V. Piotrovsky, May‐Lynn Huang, 1998, Cancer Chemotherapy and Pharmacology.

Pharmacokinetic-pharmacodynamic modeling in the data analysis and interpretation of drug-induced QT/QTc prolongation

V. Piotrovsky, Vladimir Piotrovsky, 2005, The AAPS Journal.

Effect of CYP2D6 genetic polymorphism on the population pharmacokinetics of tipifarnib

J. Pérez-Ruixo, V. Piotrovsky, V. Ozdemir, 2006, Cancer Chemotherapy and Pharmacology.

Phase I and pharmacokinetic study of farnesyl protein transferase inhibitor R115777 in advanced cancer.

C. Bowden, R. Nussenblatt, K. Cowan, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Population Pharmacokinetics of Risperidone and 9-Hydroxyrisperidone in Patients with Acute Episodes Associated with Bipolar I Disorder

E. Ludwig, A. Vermeulen, V. Piotrovsky, 2007, Journal of Pharmacokinetics and Pharmacodynamics.

Pharmacodynamic Analysis of the Interaction between Tiagabine and Midazolam with an Allosteric Model That Incorporates Signal Transduction

Meindert Danhof, M. Danhof, D. Jonker, 2003, Epilepsia.

Galantamine Population Pharmacokinetics in Patients with Alzheimer's Disease: Modeling and Simulations

A. Peer, J. Aerssens, N. Osselaer, 2003, Journal of clinical pharmacology.

Modeling the Effectiveness of Paliperidone ER and Olanzapine in Schizophrenia: Meta‐Analysis of 3 Randomized, Controlled Clinical Trials

J. Pérez-Ruixo, I. Ortega, A. Vermeulen, 2010, Journal of clinical pharmacology.